Search results
Results from the WOW.Com Content Network
The Doha Declaration on the TRIPS Agreement and Public Health was adopted by the WTO Ministerial Conference of 2001 in Doha on November 14, 2001. It reaffirmed flexibility of TRIPS (trade-related aspects of intellectual property rights) member states in circumventing patent rights for better access to essential medicines.
In 2001, developing countries, concerned that developed countries were insisting on an overly narrow reading of TRIPS, initiated a round of talks that resulted in the Doha Declaration. The Doha declaration is a WTO statement that clarifies the scope of TRIPS, stating for example that TRIPS can and should be interpreted in light of the goal "to ...
The Doha Declaration on Public Health sought to alleviate developing country dissatisfaction with aspects of the TRIPS regime. It delayed the implementation of patent system provisions for pharmaceutical products for least developed countries (LDCs) until 2016. The declaration committed member states to interpret and implement the agreement to ...
Doha conference can refer to several meetings held in Doha, Qatar: The WTO Ministerial Conference of 2001. leading to the Doha Development Round; and the Doha Declaration on the TRIPS Agreement and Public Health; 2008 follow-up conference to the Monterrey Consensus; Doha Agreement (2008) between rival Lebanese factions; Hamas–Fatah Doha ...
The Doha Declaration responds to concerns of developing countries that patent protection rules and other IPRs were hindering access to affordable medicines for populations in those countries. [19] The Doha Declaration emphasizes the flexibility of the TRIPS Agreement and highlights the right of respective government to interpret the TRIPS ...
In 2003, after two years of contentious negotiations,217 the TRIPS Council adopted the Implementation of Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health [the “Waiver Decision”], under which it instituted a temporary “waiver” allowing WTO members to grant compulsory licenses free from the obligations imposed ...
The Doha Declaration Adopted by the WTO Ministerial Conference of 2001 ; reaffirms flexibility of TRIPS member states in circumventing intellectual property rights for better access to essential medicines .
Proposals on special and differential treatment, "based on the Doha Ministerial Declaration" of 2001, were put forward at MC12. The Doha Round is still in place "on paper". [50] The WTO recognised some continuity with Doha, referring to its Ministerial Declaration as "guiding the WTO's work on special and differential treatment since 2001". [51]